Digital genome is powerful tool to analyze personal genome patterns in digital way to precisely detect any gene alteration. It is majorly used in molecular diagnosis of wide variety of disease such as cancer, infectious disease, organ transplant, and pre-natal health monitoring. Increasing incidence of infectious diseases among the global population and increasing adoption of personalized medicines for the disease treatments using patient’s genetic information are expected to aid in offering targeted treatment. This in turn is expected to create lucrative growth opportunities for the digital genome market in the near future.
Market Dynamics
Engagement of various key players and government regulatory organizations to launch digital genome-based products and services to conduct extensive research and development (R&D) in development of personalized medicines for cancer, diabetes, and other infectious diseases are expected to drive growth of the global digital genome market. Furthermore, integration of Artificial Intelligence (AI) to efficiently analyze the complex genome data and thereby, easy utilization of these genomic data by heathcare professionals, clinicians, and researchers is expected to increase adoption of digital genome technologies over the forecast period.
Increasing research in genomics and rising investments, grants, and funds by government in the field genomics are creating opportunity for the digital genome developers and providers.
For instance, the Genomics R&D Initiative (GRDI) based in Canada cooperates with other federal science departments and agencies such as Agriculture and Agri-Food Canada, the Canadian Food Inspection Agency, Environment and Climate Change Canada, the National Research Council of Canada, Natural Resources Canada, among others to carryout vital genomic research. According to the Genomics R&D Initiative (GRDI) June 2017: GRDI receives around US$ 20 million annually from Government of Canada (GoC) to conduct this research.
Key features of the study:
- This report provides in-depth analysis of digital genome market, its market size (US$ Million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2018 – 2026), considering 2018, as the base year.
- It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by key players
- It profiles key players in the global digital genome market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies.
- Key companies covered as a part of this study include, Illumina, Inc., PerkinElmer, Inc., Pacific Biosciences of California, Inc., Thermo Fisher Scientific Inc., Oxford Nanopore Technologies Limited, Nanostring Technologies, Inc., IBM Corporation, Google LLC, Amazon.com, Inc., Deep Genomics, Deep Genomics, Deep Genomics, Desktop Genetics Ltd., and Ancestry.com LLC.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future type upgradation, market expansion, and marketing tactics.
- The global digital genome market report caters to various stakeholders in this industry including investors, researchers, digital genome organizations, new entrants, and financial analysts.
- Stakeholders would have ease in decision making through the various strategy matrices used in analyzing the digital genome market.
Detailed Segmentation:
- Global Digital Genome Market, By Product Type:
- Sequencer & Analyzers
- Reagents & Kits
- Sequencing & Analysis Software
- Global Digital Genome Market, By Application:
- Clinical
- Reproductive Health
- Oncology
- Others
- Forensics
- Drug Discovery and Development
- Other Applications
- Global Digital Genome Market, By End User:
- Hospitals
- Diagnostic Centers
- Research Institutes
- Biotechnology and Pharmaceutical Companies
- Others
- Global Digital Genome Market, By Geography:
- Sequencer & Analyzers
- Reagents & Kits
- Sequencing & Analysis Software
- By Application:
- Clinical
- Reproductive Health
- Oncology
- Others
- Forensics
- Drug Discovery and Development
- Other Applications
- Hospitals
- Diagnostic Centers
- Research Institutes
- Biotechnology and Pharmaceutical Companies
- Others
- U.K.
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- Sequencer & Analyzers
- Reagents & Kits
- Sequencing & Analysis Software
- By Application:
- Clinical
- Reproductive Health
- Oncology
- Others
- Forensics
- Drug Discovery and Development
- Other Applications
- Hospitals
- Diagnostic Centers
- Research Institutes
- Biotechnology and Pharmaceutical Companies
- Others
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Sequencer & Analyzers
- Reagents & Kits
- Sequencing & Analysis Software
- By Application:
- Clinical
- Reproductive Health
- Oncology
- Others
- Forensics
- Drug Discovery and Development
- Other Applications
- Hospitals
- Diagnostic Centers
- Research Institutes
- Biotechnology and Pharmaceutical Companies
- Others
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Sequencer & Analyzers
- Reagents & Kits
- Sequencing & Analysis Software
- By Application:
- Clinical
- Reproductive Health
- Oncology
- Others
- Forensics
- Drug Discovery and Development
- Other Applications
- Hospitals
- Diagnostic Centers
- Research Institutes
- Biotechnology and Pharmaceutical Companies
- Others
- GCC
- Israel
- Rest of Middle East
- Sequencer & Analyzers
- Reagents & Kits
- Sequencing & Analysis Software
- By Application:
- Clinical
- Reproductive Health
- Oncology
- Others
- Forensics
- Drug Discovery and Development
- Other Applications
- Hospitals
- Diagnostic Centers
- Research Institutes
- Biotechnology and Pharmaceutical Companies
- Others
- North Africa
- Central Africa
- South Africa
- Sequencer & Analyzers
- Reagents & Kits
- Sequencing & Analysis Software
- By Application:
- Clinical
- Reproductive Health
- Oncology
- Others
- Forensics
- Drug Discovery and Development
- Other Applications
- Hospitals
- Diagnostic Centers
- Research Institutes
- Biotechnology and Pharmaceutical Companies
- Others
- Company Profiles
- Illumina, Inc.*
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments
- PerkinElmer, Inc.
- Pacific Biosciences of California, Inc.
- Thermo Fisher Scientific Inc.
- Oxford Nanopore Technologies Limited
- Nanostring Technologies, Inc.
- IBM Corporation
- Google LLC
- Amazon.com, Inc.
- Deep Genomics
- GenomeMe
- 23andMe
- Desktop Genetics Ltd.
- Ancestry.com LLC
“*” marked represents similar segmentation in other categories in the respective section.
